RaySearch Laboratories has entered into an exclusive distribution agreement with the Chinese distributor Kang Li Da Trading, based in Beijing. The agreement means that Kang Li Da will be fully responsible for marketing, sales and service for RaySearch’s proprietary treatment planning system RayStation on the entire Chinese market.
China is one of the largest radiation therapy markets globally with approximately 1300 radiation therapy clinics. There is a strong focus on improving healthcare so the radiation therapy sector is growing very rapidly and the number of clinics is expected to increase to 2,000 in less than five years. RayStation is pending regulatory clearance in China and the approval process is expected to last approximately a year and a half.
Kang Li Da was founded in 1996 and is a leading distributor of radiation therapy equipment in China. The company has approximately 20 employees and represents a wide range of international radiation therapy equipment suppliers serving more than 500 customers.
“China is the fastest growing radiation therapy market so this agreement is extremely important to us. Kang Li Da is a highly experienced distributor of radiation therapy equipment with a broad geographical coverage and excellent track record. We are very excited that they have selected to work exclusively with us within treatment planning and we are looking forward to work closely together to establish RayStation as a leading product on the Chinese market," said Johan Löf, CEO of RaySearch.